Engineered T cells and immune checkpoint inhibitors show promise for treating GI cancers
Two new strategies are emerging to treat GI and other cancers — engineered T cells and immune checkpoint blockade treatments.
Two new strategies are emerging to treat GI and other cancers — engineered T cells and immune checkpoint blockade treatments.
Andrew P. Keaveny, MD, FRCPI, FAASLD
Consultant Hepatologist and Medical Director of Liver Transplant, Mayo Clinic, Jacksonville, Florida; Associate Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, AASLD Annual Meeting Education Committee; Member of the AASLD Maintenance of Certification and Scientific Planning Committees
CRC screening guidelines vary around the world. The U.S. is one of the only countries, for example, that relies heavily on colonoscopies for CRC screening in average-risk populations. Other countries tend to rely on less expensive and less invasive screening technologies for average-risk screening.
The ASGE International Program at DDW® culminates on Tuesday with four joint symposia, including concurrent sessions with the Australian Gastrointestinal Endoscopy Association (AGEA) and the Chinese Society of Gastroenterology (CSGE).
Clostridium difficile colitis does not happen in a vacuum. When, why and how C. diff populations explode and cause colitis is the result of a complex interplay among bacteria, human host, the gut microbiome and the environment.
During Tuesday’s Best of ASGE DDW en Español session, gastroenterology experts from Spanish-speaking countries will summarize the top endoscopic sessions at DDW® in five topic areas.
Medicare payment systems are undergoing perhaps the greatest change since Medicare was enacted in 1965 due to a law known as MACRA, the Medicare Access and CHIP Reauthorization Act of 2015.
Adequate nutrition is important for growth and meeting developmental milestones for all children. But for pediatric liver patients, overnutrition or undernutrition can have devastating effects.
Eight experts will discuss novel endoscopic approaches for the treatment of obesity during Tuesday’s Kelly and Carlos Pelligrini SSAT and SAGES Luncheon Symposium. The annual symposium, which qualifies for up to three hours of CME credit and does not require a ticket, is co-sponsored by SSAT and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
Amit H. Sachdev, MD
Gastroenterology Fellow, Future Interventional Endoscopy Fellow, Columbia University College of Physicians and Surgeons, NY
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.